FDA approves Lipitor for high-risk cardio patients

The FDA has given five new approvals for Pfizer's blockbuster Lipitor, with its sanction for reducing the risk of heart attacks and strokes and for heart surgery. Originally approved as a cholesterol-lowering drug, Lipitor is now approved for high-risk cardiovascular patients. It's a big market. Pfizer notes that more than 15 million Americans have a history of heart disease.

- check out Pfizer's release on the approvals
- read the AP report on the approvals

Related Articles:
Pfizer wins key Lipitor ruling in UK court. Report
Investors cheer Lipitor patent decision. Report
Pfizer halts Torcetrapib development. Report